Supplemental materials for the review "Levothyroxine: Impaired bioavailability and novel drug delivery formulations"
Published: 24 March 2022| Version 1 | DOI: 10.17632/xsz6d54tjb.1
Contributor:
Ben TsingDescription
Supplemental materials for the review "Levothyroxine: Impaired bioavailability and novel drug delivery formulations" Supplementary table 1. Summary of clinical studies evaluating the bioavailability of liquid LT4 and soft gel capsule in cases with interfering factors. Supplementary table 2. Summary of application of nanomaterials in the drug delivery of levothyroxine. Supplementary figure 1. The flow chart of included articles.
Files
Steps to reproduce
The authors collected the data from the articles listed in the references.
Institutions
Wuhan University Renmin Hospital, Wuhan University
Categories
Peer Review